Financial News
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
March 29, 2025
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
March 28, 2025
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
March 27, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
March 25, 2025
From CNBC.com News
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24, 2025
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
March 24, 2025
From CNBC.com News
Zepbound copycats remain online despite FDA ban
March 21, 2025
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Monday
March 10, 2025
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
March 10, 2025
From CNBC.com News
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
March 05, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
February 20, 2025
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
February 13, 2025
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 10, 2025
From CNBC.com News
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
January 28, 2025
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
